Patents by Inventor Hyunjeung CHOI

Hyunjeung CHOI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising same
    Patent number: 11261482
    Abstract: The present invention relates to a composition for detecting an epidermal cell growth factor receptor gene mutation and to a kit comprising the composition and, more specifically, to a primer and probe set composition for detecting an epidermal cell growth factor gene mutation, and to a kit for detecting an EGFR gene mutation, comprising the composition. A method according to the present invention can not only predict and diagnose responsiveness to a therapeutic agent for the prognosis of a cancer patient, but also predict a cancer metastasis or relapse Thus, the method can be useful for the purposes of determining the need to administer an anticancer therapeutic agent and guiding the direction of future treatment, and for monitoring a cancer metastasis or relapse.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: March 1, 2022
    Assignee: GENCURIX INC
    Inventors: Young Kee Shin, Bohyun Byun, Hyunjeung Choi, Joon Seok Choi, Young Ho Moon, Jong Heun Lee, Sang Rea Cho, Jee Eun Kim, Myungsun Kim
  • COMPOSITION FOR DETECTING EPIDERMAL CELL GROWTH FACTOR RECEPTOR GENE MUTATION, AND KIT COMPRISING SAME
    Publication number: 20190352703
    Abstract: The present invention relates to a composition for detecting an epidermal cell growth factor receptor gene mutation and to a kit comprising the composition and, more specifically, to a primer and probe set composition for detecting an epidermal cell growth factor gene mutation, and to a kit for detecting an EGFR gene mutation, comprising the composition. A method according to the present invention can not only predict and diagnose responsiveness to a therapeutic agent for the prognosis of a cancer patient, but also predict a cancer metastasis or relapse Thus, the method can be useful for the purposes of determining the need to administer an anticancer therapeutic agent and guiding the direction of future treatment, and for monitoring a cancer metastasis or relapse.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 21, 2019
    Inventors: Young Kee SHIN, Bohyun BYUN, Hyunjeung CHOI, Joon Seok CHOI, Young Ho MOON, Jong Heun LEE, Sang Rea CHO, Jee Eun KIM, Myungsun KIM